Drug-Induced Diseases

Prevention, Detection, and Management

Restricted access
Buy Book in ASHP Store

List Price: $258.00 

Member Price: $196.00

Page Count: 1426

Now in its third edition, this comprehensive guide provides a detailed overview of diseases that result from drug therapy, arming healthcare professionals with critical knowledge to protect the health and welfare of their patients.

NOTE: The link below allows you to download the ePub file. If you want the PDF files, click on Table of Contents, browse the chapters by clicking on the drop-down symbol ^, select a chapter, and you will see the DOWNLOAD PDF orange button in the upper right. Most ePub files can be opened in eBook readers, like the B&N Nook and Kobo eReader. These files have to be converted to .Mobi format before they are usable on the Amazon Kindle device or app. For your computer, the easiest way to open an ePub file is to double-click on it and let your PC decide which default application should open the file. If no program opens it, then you probably do not have an application installed that can view ePub files. ePub files can also be opened on a computer with various free programs including Adobe Digital Editions. If you have access to this title you can download the ePub here:

    • Drug-Induced Diseases (EPUB 13.1 MB)
    • Drug-Induced Diseases (PDF 18.3 MB)

Protect Your Patients: A Definitive Guide to Drug-Induced Disease

A drug-induced disease is the unintended effect of a drug, which results in mortality or morbidity with symptoms sufficient to prompt a patient to seek medical attention and/or require hospitalization. This book, now a modern classic, examines these unintended effects and creates a knowledge base of potentially causal drugs that must be considered in medication monitoring activities.   

Now in its third edition, this essential and comprehensive resource provides a detailed analysis of how to identify, prevent, and manage drug-induced diseases. Edited by James E. Tisdale and Douglas A. Miller, with contributions from experts distinguished in their respective specialties, Drug-Induced Diseases is organized logically and is easy to use for pharmacists, physicians, nurses, and pharmacy students alike.

James E. Tisdale, PharmD, BCPS, FCCP

James E. Tisdale is Professor of Pharmacy Practice in the Department of Pharmacy Practice Personnel at the Purdue University School of Pharmacy and Pharmaceutical Sciences in Indianapolis, IN. He received his BSc Pharm from the University of Manitoba in 1983 and his PharmD from S.U.N.Y. at Buffalo in 1988. He completed a pharmacy practice residency at the University of Manitoba Health Science Center in 1984 and a fellowship in cardiovascular therapeutics at Hartford Hospital (CT) from 1988 to 1990.

Dr. Tisdale’s research interests are in the area of cardiovascular pharmacotherapy, focusing on mechanisms, risk factors, and management of drug-induced arrhythmias, and drug therapy for prevention and treatment of atrial fibrillation. His research has resulted in the publication of nearly 50 journal articles, 6 book chapters, and 40 research abstracts in addition to his co-editorship of Drug-Induced Diseases: Prevention, Detection, and Management.

Dr. Tisdale’s research has been funded by the American Heart Association, numerous foundations, and the pharmaceutical industry. From 2001 to 2004, he was a member of the Board of Regents of the American College of Clinical Pharmacy, and from 2008 to 2009 he was Chair, Clinical Sciences Section, Academy of Pharmaceutical Research and Science, American Pharmacists Association. Dr. Tisdale is currently President-Elect of the American College of Clinical Pharmacy.


Douglas A. Miller, PharmD

Douglas A. Miller is Professor, Wayne State University Eugene Applebaum College of Pharmacy and Health Sciences in Detroit, where he teaches courses dealing with professional practice and patient care. He earned his BS in Pharmacy from The Ohio State University College of Pharmacy and his PharmD from the Philadelphia College of Pharmacy and Science. His pharmacy experience includes practice in community, long-term care, and hospital settings. For more than 20 years, he led a team that conceptualized and implemented innovative clinical pharmacy services at Detroit’s Henry Ford Hospital.

Dr. Miller served as a member of the Michigan Board of Pharmacy for 11 years including two terms as board chair. He has also served as a member of the Board of Trustees of the American Pharmacists Association and the boards of both the Michigan Pharmacists Association and the Michigan Society of Health-System Pharmacists. He is the recipient of several awards and honors including the Annual Alumni Award of the University of the Sciences in Philadelphia and the Distinguished Alumni Award of The Ohio State University College of Pharmacy, the Pharmacist of the Year Award of the Michigan Pharmacists Association, and awards from both ASHP and APhA for outstanding practice in hospital pharmacy. In 1990, 1991, 1995, 2004, and 2007, he was named Teacher of the Year at the Wayne State University Applebaum College of Pharmacy and Health Sciences. Dr. Miller is a Fellow of the American Pharmacists Association.